Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Annual Report Semi-Annual Report Quarterly Report

JCARE 2024 Annual Report

Time:2025-04-07

JCARE 2023 Annual Report

Time:2024-04-02

JCARE 2022 Annual Report

Time:2023-04-10

Joincare's 2021 Annual Report

Time:2022-03-30

Joincare's 2020 Annual Report

Time:2021-03-31

Joincare's 2019 Annual Report

Time:2020-04-11

Joincare's 2018 Annual Report

Time:2019-04-16

< 1 >

JCARE 2024 Interim Report

Time:2024-08-23

JCARE 2023 Interim Report

Time:2023-08-23

Joincare's 2022 Semi-Annual Report

Time:2022-08-11

Joincare's ​2021 Semi-Annual Report

Time:2021-09-26

Joincare's 2020 Semi-Annual Report

Time:2020-08-28

Joincare's ​2019 Semi-Annual Report

Time:2019-08-27

< 1 >

Ad hoc announcement pursuant to Art. 53 LR -JCARE 2025 First Quarterly Report

Time:2025-04-24

Joincare Pharmaceutical Group Industry Co., Ltd. 2024 Third Quarterly Report

Time:2024-10-24

Joincare Pharmaceutical Group Industry Co., Ltd. 2024 First Quarterly Report

Time:2024-04-25

Joincare Pharmaceutical Group Industry Co., Ltd. 2023 Third Quarterly Report

Time:2023-10-25

Joincare Pharmaceutical Group Industry Co., Ltd. 2023 First Quarterly Report

Time:2023-04-24

Joincare Pharmaceutical Group Industry Co., Ltd. 2022 Third Quarterly Report

Time:2022-10-26

Joincare's 2022 first quarter report

Time:2022-04-29

Joincare's 2021 third quarter report

Time:2021-10-27

Joincare's 2020 first quarter report

Time:2020-04-28

Joincare's 2019 third quarter report

Time:2019-11-08

< 12 >

Our company strictly follows the requirements of laws and regulations such as the "Company Law of the People's Republic of China", the "Securities Law of the People's Republic of China", the "Corporate Governance Guidelines for Listed Companies", and the "Rules for Stock Listing on the Shanghai Stock Exchange", continuously improving the company's corporate governance structure, strengthening information disclosure, improving investor relations management, continuously strengthening and improving the company's internal control, and standardizing the company's operations.